香煙中含有許多烷基化試劑,研究顯示抽菸會導致DNA受到乙基化試劑的傷害而產生3-乙基腺嘌呤(3-ethyladenine)及7-乙基鳥糞嘌(7-ethylguanine) DNA加成產物。為了準確定量在DNA上的乙基加成產物,我利用中性熱水解方法使3-乙基腺嘌呤和7-乙基鳥糞嘌呤從白血球DNA上被釋出,透過固相萃取管柱的樣品前處理步驟,再以穩定同位素稀釋毛細管液相層析奈電噴灑游離串聯質譜法,在高選擇反應追蹤模式(H-SRM)下去偵測這些被釋出的3-EtA和7-EtG。3-乙基腺嘌呤及7-乙基鳥糞嘌呤的偵測極限分別為30.7 和55.9 amol。在20位吸菸者的白血球DNA中,108個正常核苷酸中有16.0 ± 7.8個3-乙基腺嘌呤與9.7 ± 8.3個7-乙基鳥糞嘌呤;在20位非吸菸者中,108個正常核苷酸中有5.4 ± 2.6個3-乙基腺嘌呤與0.3 ± 0.8個7-乙基鳥糞嘌呤,比較此二加成產物在吸菸者與非吸菸者之含量,其p值皆小於0.0001。經由體內修復系統修復的加成產物則被排放到尿液當中,因此我透過固相萃取管柱的樣品前處理步驟,再以毛細管液相層析奈電噴灑游離串聯質譜法,在H-SRM下同時分析尿液中3-乙基腺嘌呤及7-乙基鳥糞嘌呤的含量。在5位吸菸者的尿液中,3-乙基腺嘌呤濃度為120.9 ± 33.5 pg/mL,7-乙基鳥糞嘌呤濃度為61.0 ± 8.5 pg/mL。我希望藉由此分析方法來評估DNA受到乙基化損害的程度,比較出3-乙基腺嘌呤和7-乙基鳥糞嘌呤與疾病的相關性,做為癌症風險評估的生化指標。
Cigarette smoke contains many alkylating agents which damage DNA producing DNA adducts, such as 3-ethyladenine (3-EtA) and 7-ethylguanine (7-EtG). To quantify ethylated adducts on DNA, I used neutral thermal hydrolysis to release 3-EtA and 7-EtG from DNA. The adducts were purified by a reversed-phase solid-phase extraction column and analyzed by stable isotope dilution capillary liquid chromatography nanospray ionization tandem mass spectrometry (capLC-NSI/MS/MS) under the highly selected reaction monitoring (H-SRM) mode. The amount of ethylated DNA adducts represents the steady-state levels of DNA adducts resulting from the ethylating agent after repair in vivo. The detection limit of 3-EtA and 7-EtG was 30.7 and 55.9 amol, respectively. Levels of 3-EtA and 7-EtG are 16.0 ± 7.8 and 9.7 ± 8.3 in 108 normal nucleotides, respectively, in white blood cells (WBC) DNA of 20 smokers, which are statistically significantly higher than those in 20 nonsmokers with 5.4 ± 2.6 3-EtA and 0.3 ± 0.8 7-EtG in 108 normal nucleotides (p < 0.0001). These DNA adducts are repaired in vivo and then released in human urine. The urine samples were purified by a mixed-mode cation exchange followed by a reversed-phase solid-phase extraction column and analyzed by capLC-NSI/MS/MS under the H-SRM. The urinary concentration of 3-EtA and 7-EtG are 120.9 ± 33.5 pg/mL and 61.0 ± 8.5 pg/mL in 5 smokers. The highly sensitive and specific stable isotope dilution nanoLC-NSI/MS/MS assay should be clinically useful in assessing the possibility of measuring ethylpurines in human WBC DNA and in urine as risk biomarkers for smoking-related cancers.